Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Archives of cardiovascular diseases
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le dimanche 27 octobre 2019
Doi : 10.1016/j.acvd.2019.10.001
Received : 4 October 2019 ;  accepted : 4 October 2019
Erratum to “Proprotein convertase subtilisin/kexin type 9 inhibitors: New insights into cardiovascular atherosclerotic pathophysiology with therapeutic implications” [Arch Cardio Dis. (2019) 455–4588]
Erratum to “Les inhibiteurs PCSK9 réflexions sur la pathophysiologie de l’athérosclérose : implications thérapeutiques” [Arch Cardio Dis. (2019) 455–4588]
 

Dennis V. Cokkinos a, , Philip Cokkinos b, Genovefa Kolovou b
a Biomedical Research Foundation Academy of Athens (BRFAA), Heart and Vessel Department, 4, Soranou Ephessiou street, 11527 Athens, Greece 
b Cardiology Department, Onassis Cardiac Surgery Center, Sygrou 376, Kallithea, Athens, Greece 

Corresponding author.


© 2019  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline